Viewing Study NCT00618657


Ignite Creation Date: 2025-12-24 @ 6:45 PM
Ignite Modification Date: 2026-01-04 @ 12:30 AM
Study NCT ID: NCT00618657
Status: COMPLETED
Last Update Posted: 2024-02-28
First Post: 2008-02-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
Sponsor: University of California, Irvine
Organization: